Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Teck Lim

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Cancer Treatment and Research Communications|August 13, 2025
Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in IndonesiaNoni Novisari Soeroso, Elisna Syahruddin, Chaliza Soliha, et al.
Cancers|March 28, 2025
Development of a miRNA-Based Model for Lung Cancer DetectionKai Chin Poh, Toh Ming Ren, Goh Liuh Ling, et al.
Head & Neck|July 8, 2026
Metastatic Count and Local Ablative Therapy Influence Survival Outcomes in Oligometastatic Nasopharyngeal Carcinoma PatientsWanyi Kee, Mei-Kim Ang, Darren Wan-Teck Lim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2013
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaWhay-Kuang Chia, Marissa Teo, Who-Whong Wang, et al.
Plos One|July 8, 2014
Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cellsBee Luan Khoo, Majid Ebrahimi Warkiani, Daniel Shao-Weng Tan, et al.
Plos One|September 26, 2019
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platformYoon-Sim Yap, Man Chun Leong, Yong Wei Chua, et al.
Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
Science Advances|November 23, 2022
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer modelWai Nam Liu, Wing Yan So, Sarah L Harden, et al.
Targeted Oncology|October 24, 2023
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaAlbiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, et al.
Translational Lung Cancer Research|May 17, 2023
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistanceJun Ma, Sze Huey Tan, Daniel Xing Cheng Yin, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Cancer Treatment and Research Communications|August 13, 2025
Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in IndonesiaNoni Novisari Soeroso, Elisna Syahruddin, Chaliza Soliha, et al.
Cancers|March 28, 2025
Development of a miRNA-Based Model for Lung Cancer DetectionKai Chin Poh, Toh Ming Ren, Goh Liuh Ling, et al.
Head & Neck|July 8, 2026
Metastatic Count and Local Ablative Therapy Influence Survival Outcomes in Oligometastatic Nasopharyngeal Carcinoma PatientsWanyi Kee, Mei-Kim Ang, Darren Wan-Teck Lim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2013
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaWhay-Kuang Chia, Marissa Teo, Who-Whong Wang, et al.
Plos One|July 8, 2014
Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cellsBee Luan Khoo, Majid Ebrahimi Warkiani, Daniel Shao-Weng Tan, et al.
Plos One|September 26, 2019
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platformYoon-Sim Yap, Man Chun Leong, Yong Wei Chua, et al.
Human Genomics|July 17, 2023
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancerNing-Yuan Lee, Melissa Hum, Sabna Zihara, et al.
Science Advances|November 23, 2022
Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer modelWai Nam Liu, Wing Yan So, Sarah L Harden, et al.
Targeted Oncology|October 24, 2023
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaAlbiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, et al.
Translational Lung Cancer Research|May 17, 2023
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistanceJun Ma, Sze Huey Tan, Daniel Xing Cheng Yin, et al.
Pageof 14